Close

Medtronic (MDT) Announced Evera MRI SureScan ICD Met Safety, Efficacy Endpoints in MRI Scan Trial

May 14, 2015 3:04 PM EDT Send to a Friend
Medtronic (NYSE: MDT) announced clinical trial results for the Medtronic Evera MRI SureScan implantable cardioverter defibrillator (ICD) following MRI scans ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login